Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1995-4-21
pubmed:abstractText
We studied rejection, allograft function and side effects, such as hypertension, renal dysfunction and hypercholesterolemia, in seven patients switched from cyclosporine-based triple-drug immunosuppression to FK 506.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0735-1097
pubmed:author
pubmed:issnType
Print
pubmed:volume
25
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1183-8
pubmed:dateRevised
2010-3-24
pubmed:meshHeading
pubmed-meshheading:7534779-Adolescent, pubmed-meshheading:7534779-Adult, pubmed-meshheading:7534779-Antihypertensive Agents, pubmed-meshheading:7534779-Azathioprine, pubmed-meshheading:7534779-Child, pubmed-meshheading:7534779-Cyclosporine, pubmed-meshheading:7534779-Drug Therapy, Combination, pubmed-meshheading:7534779-Echocardiography, pubmed-meshheading:7534779-Follow-Up Studies, pubmed-meshheading:7534779-Graft Rejection, pubmed-meshheading:7534779-Heart Catheterization, pubmed-meshheading:7534779-Heart Transplantation, pubmed-meshheading:7534779-Humans, pubmed-meshheading:7534779-Hyperlipidemias, pubmed-meshheading:7534779-Hypertension, pubmed-meshheading:7534779-Immunosuppression, pubmed-meshheading:7534779-Kidney Diseases, pubmed-meshheading:7534779-Lymphoproliferative Disorders, pubmed-meshheading:7534779-Prednisone, pubmed-meshheading:7534779-Tacrolimus, pubmed-meshheading:7534779-Time Factors
pubmed:year
1995
pubmed:articleTitle
Immunosuppression switch in pediatric heart transplant recipients: cyclosporine to FK 506.
pubmed:affiliation
Department of Pediatric Cardiology and Cardiac Surgery, Children's Hospital of Pittsburgh, University of Pittsburgh, Pennsylvania 15213.
pubmed:publicationType
Journal Article